From intracellular biomolecule delivery to prophylactic cancer immunotherapy: a nine-year research journey
We showed that the PLLA–ZnO/CEA nano vaccine activates dendritic cells, generates balanced antibody and T-cell immunity, remodels the tumor microenvironment, and reduces tumor burden by 65–70% following prophylactic vaccination in mice.